Results 331 to 340 of about 632,804 (356)

An update on the management of postoperative nausea and vomiting

Journal of Anesthesia, 2017
Xuezhao Cao, P. White, Hong Ma
semanticscholar   +1 more source

Cyclic vomiting syndrome is a prevalent and under‐recognized condition in the gastroenterology outpatient clinic

Neurogastroenterology and Motility, 2018
R. Sagar, R. Sood, D. Gracie, M. Gold, N. To, Graham R. Law, A. Ford   +6 more
semanticscholar   +1 more source

PLAGIOCEPHALY AND VOMITING

Medical Journal of Australia, 1963
openaire   +2 more sources

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Journal of Clinical Oncology, 2003
Richard J Gralla, Fausto Roila, Alexandra D Carides   +2 more
exaly  

Vomiting

2011
openaire   +1 more source

Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

Journal of Clinical Oncology, 2005
Richard J Gralla, Anthony Rodgers
exaly  

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Lancet Oncology, The, 2009
Hiroshi Sakai
exaly  

Evidence for a Re-Evaluation of the Neurochemical and Anatomical Bases of Chemotherapy-Induced Vomiting

Chemical Reviews, 2009
Nissar A Darmani
exaly  

Prevention and Treatment of Postoperative Nausea and Vomiting

Drugs, 2012
Anthony L Kovac
exaly  

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials

Lancet Oncology, The, 2015
Lee S Schwartzberg, Rudolph M Navari
exaly